A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia
ConclusionAfter a year of exposure, SZC treatment was well tolerated by Japanese patients and potassium levels were well controlled.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Constipation | Hypertension | Japan Health | Potassium | Sodium | Study | Urology & Nephrology